Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COOL: Switching to TDF+3TC+EFV vs TDF+EFV in HIV
NCT00643968Phase 4Completed
- Sponsor
- Gilead Sciences
- Start
- Mar 2003
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lamivudine in human immunodeficiency virus infection (HIV), sponsored by Gilead Sciences. Started Mar 2003; status: completed.
02
Drugs
lamivudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00643968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00643968.